Verinurad
Showing 1 - 21 of 21
Healthy Volunteers (Intended Indication: Chronic Kidney Disease) Trial in Berlin (Verinurad, Placebo, Allopurinol)
Completed
- Healthy Volunteers (Intended Indication: Chronic Kidney Disease)
- Verinurad
- +2 more
-
Berlin, GermanyResearch Site
Nov 29, 2021
Chronic Kidney Disease Trial in Berlin (Verinurad prolonged release HPMC capsule, Allopurinol Tablet, Verinurad/Allopurinol FDC
Completed
- Chronic Kidney Disease
- Verinurad prolonged release HPMC capsule
- +3 more
-
Berlin, GermanyResearch Site
Jul 20, 2021
Chronic Kidney Disease Trial in Berlin (Verinurad ER8 capsule formulation (fasted), Verinurad A-capsule formulation (fasted),
Completed
- Chronic Kidney Disease
- Verinurad ER8 capsule formulation (fasted)
- +4 more
-
Berlin, GermanyResearch Site
Feb 23, 2021
Chronic Kidney Disease Trial in Berlin (Verinurad, Allopurinol, Cyclosporine)
Completed
- Chronic Kidney Disease
- Verinurad
- +3 more
-
Berlin, GermanyResearch Site
Dec 7, 2020
Chronic Kidney Disease Trial in Worldwide (Verinurad, Allopurinol, Placebo for Verinurad)
Completed
- Chronic Kidney Disease
- Verinurad
- +3 more
-
Huntsville, Alabama
- +165 more
Jan 19, 2022
Hyperuricemia, Albuminuria, Type 2 Diabetes Trial in United States (Verinurad 9 mg+Febuxostat 80 mg, Placebo)
Completed
- Hyperuricemia
- +2 more
- Verinurad 9 mg+Febuxostat 80 mg
- Placebo
-
Canyon Country, California
- +17 more
Dec 18, 2019
Chronic Kidney Disease Trial in Glendale (Verinurad, Allopurinol, Placebo)
Completed
- Chronic Kidney Disease
- Verinurad
- +2 more
-
Glendale, CaliforniaResearch Site
May 10, 2019
Asymptomatic Hyperuricemia Trial in Glendale, Baltimore (Verinurad, Febuxostat, Dapagliflozin)
Completed
- Asymptomatic Hyperuricemia
- Verinurad
- +3 more
-
Glendale, California
- +1 more
Aug 14, 2019
Gout and Hyperuricemia Trial in Japan (RDEA3170, Allopurinol, Placebo)
Gout Trial in Overland Park (RDEA3170 10 mg, allopurinol 300 mg)
Completed
- Gout
- RDEA3170 10 mg
- allopurinol 300 mg
-
Overland Park, Kansas(unnamed)
Dec 19, 2017
Gout Trial in United States (RDEA3170 2.5 mg, allopurinol 300 mg)
Completed
- Gout
- RDEA3170 2.5 mg
- allopurinol 300 mg
-
Anaheim, California
- +3 more
Dec 20, 2017
Gout Trial in Austin (RDEA3170 4.5 mg, RDEA3170 6 mg, RDEA3170 12 mg)
Completed
- Gout
- RDEA3170 4.5 mg
- +2 more
-
Austin, Texas(unnamed)
Aug 31, 2016
Gout Trial in United States (Placebo, RDEA3170 5 mg, RDEA3170 10 mg)
Completed
- Gout
- Placebo
- +3 more
-
Birmingham, Alabama
- +49 more
Jun 4, 2015
Gout and Asymptomatic Hyperuricemia Trial in Fukuoka-shi (RDEA3170, Febuxostat, Benzbromarone)
Completed
- Gout and Asymptomatic Hyperuricemia
- RDEA3170
- +2 more
-
Fukuoka-shi, JapanResearch Site
Jun 11, 2015
Healthy Trial in Madison (RDEA3170 10 mg)
Completed
- Healthy
- RDEA3170 10 mg
-
Madison, Wisconsin(unnamed)
Jan 8, 2014
Healthy Trial in Kalamazoo (RDEA3170 10 mg, Febuxostat 40 mg, )
Completed
- Healthy
- RDEA3170 10 mg
- +2 more
-
Kalamazoo, Michigan(unnamed)
Jan 8, 2014
Gout Trial in Glendale (RDEA3170 and Placebo)
Completed
- Gout
- RDEA3170 and Placebo
-
Glendale, California(unnamed)
Jan 8, 2014